Verum Research LLC
Verum Research LLC
Eugene, Oregon, United States9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) | Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-30 | NCT06635148 | |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy | Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 3 | 2026-09-18 | NCT06541704 | |
| A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56 | wet macular degeneration | Active, not recruiting | Phase 3 | 2026-09-03 | NCT06668064 | |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME) | diabetic macular edema | Active, not recruiting | Phase 1 | 2026-09-02 | NCT06847854 | |
| Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM | eye disorder, preretinal fibrosis, retinal disorder | Recruiting | Not applicable | 2026-07-16 | NCT05145491 | |
| Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD | Neovascular Age-related Macular Degeneration | Active, not recruiting | Phase 3 | 2026-07-07 | NCT05904028 | |
| Fenofibrate for Prevention of DR Worsening | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-06-29 | NCT04661358 | |
| Evaluation of Tonabersat for DME | diabetic macular edema | Active, not recruiting | Phase 2 | 2025-12-11 | NCT05727891 | |
| Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study | Eye Diseases, Hereditary, Geographic Atrophy, Skin Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, eye disorder, macular degeneration, primary anetoderma, retinal degeneration, retinal disorder, skin disorder | Active, not recruiting | Not stated | 2025-06-13 | NCT05797896 |